HIGHLIGHTS
- who: Gulcin Tezcan et al. from the Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia have published the Article: Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells, in the Journal: (JOURNAL)
- what: The authors aimed to investigate the impact of Az, a macrolide , and ceftriaxone (Cf), a lactamide , antibiotics on NLRP3 expression in LPS-primed cancer cells.
- how: The data showed that LPS-Cf decreased NLRP3 and pro-IL-1β RNA expression and reduced these proteins production as compared to LPS-only. Were collected using an Infinite . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.